Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability

Anderson MS, Nadkarni A, Cardwell LA, Alinia H, Feldman SR

Patient Preference and Adherence 2017, 11:1143-1150

Published Date: 6 July 2017